Loading…
CIK 0001622627 • 6 13F filings • May 14, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("rosalind-advisors-inc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP | PUT | $1.9M | 0.7% | 1,168,600 SH | New |
| ARRIVENT BIOPHARMA INC | CALL | $540K | 0.2% | 107,900 SH | New |
| ARRIVENT BIOPHARMA INC | COM | $4.3M | 1.5% | 215,871 SH | New |
| ASTRIA THERAPEUTICS INC | COM | $13.6M | 4.8%Prev: 0.4% | 1,039,080 SH | Increased-503,440 SH |
| BIOFRONTERA INC | COM NEW | $650K | 0.2%Prev: 0.4% | 1,140,764 SH | Decreased |
| CG ONCOLOGY INC | COM | $12.5M | 4.4%Prev: 4.1% | 300,000 SH | Increased |
| CYBIN INC | COM NEW | $13.6M | 4.8%Prev: 3.0% | 1,657,540 SH | Increased+157,540 SH |
| CYTOKINETICS INC | COM NEW | $12.4M | 4.4%Prev: 7.5% | 195,045 SH | Decreased-204,955 SH |
| DELCATH SYSTEMS, INC. | COM NEW | $33.0M | 11.6% | 3,300,389 SH | New |
| EYEPOINT PHARMACEUTICALS INC | COM NEW | $12.6M | 4.4%Prev: 3.2% | 690,000 SH | Increased+40,000 SH |
| FENNEC PHARMACEUTICALS INC | COM | $20.1M | 7.1%Prev: 6.6% | 2,613,508 SH | Increased+536,668 SH |
| FRACTYL HEALTH INC | COM | $849K | 0.3%Prev: 2.7% | 385,731 SH | Decreased-4,614,269 SH |
| INSPIREMD INC | COM | $7.0M | 2.4%Prev: 3.2% | 3,905,743 SH | Decreased |
| INVESCO QQQ TR | PUT | $3.0M | 1.1%Prev: 0.5% | 450,000 SH | Increased+200,000 SH |
| ISHARES TR | PUT | $1.1M | 0.4%Prev: 0.0% | 200,000 SH | Increased |
| KURA ONCOLOGY INC | COM | $1.0M | 0.4%Prev: 0.3% | 100,000 SH | Increased |
| MEDIWOUND LTD | SHS NEW | $13.8M | 4.9%Prev: 4.6% | 749,054 SH | Increased |
| MIND MEDICINE MINDMED INC | COM NEW | $10.0M | 3.5%Prev: 3.0% | 750,000 SH | Increased |
| MYOMO INC | COM NEW | $3.5M | 1.2%Prev: 1.2% | 3,839,772 SH | Increased+48,984 SH |
| NEURAXIS INC | COM | $1.0M | 0.4% | 286,138 SH | New |
| Ocular Therapeutix, Inc | COM | $4.9M | 1.7% | 400,000 SH | New |
| ONKURE THERAPEUTICS INC | COM CL A | $2.1M | 0.7% | 730,488 SH | New |
| POLYPID LTD | COM | $3.0M | 1.1%Prev: 1.0% | 696,556 SH | Decreased-222,112 SH |
| PROFOUND MEDICAL CORP | COM NEW | $8.4M | 3.0% | 1,068,955 SH | New |
| REGENTIS BIOMATERIALS LTD | ORDINARY SHARES | $1.7M | 0.6% | 251,510 SH | New |
| REPLIMUNE GROUP INC | CALL | $12K | 0.0%Prev: 0.1% | 230,900 SH | Decreased-280,500 SH |
| REPLIMUNE GROUP INC | COM | $13.7M | 4.8% | 1,410,497 SH | New |
| SAVARA INC | COM | $20.5M | 7.2%Prev: 4.9% | 3,403,721 SH | Increased-596,279 SH |
| SPDR S&P 500 ETF TR | PUT | $1.9M | 0.7%Prev: 0.2% | 510,000 SH | Increased+210,000 SH |
| SPDR SERIES TRUST | PUT | $1.3M | 0.5%Prev: 0.3% | 1,937,600 SH | Increased-190,700 SH |
| TALPHERA INC | COM NEW | $4.1M | 1.4%Prev: 1.3% | 3,579,273 SH | Increased-806,484 SH |
| TREVI THERAPEUTICS INC | COM | $1.3M | 0.4%Prev: 0.3% | 100,000 SH | Increased |
| UNIQURE NV | CALL | $95K | 0.0% | 100,000 SH | New |
| VERASTEM INC | CALL | $160K | 0.1%Prev: 0.3% | 268,600 SH | Decreased-377,900 SH |
| VERASTEM INC | COM NEW | $13.8M | 4.9%Prev: 5.8% | 1,788,475 SH | Decreased-141,088 SH |
| VIKING THERAPEUTICS INC | CALL | $2K | 0.0% | 100,000 SH | New |
| VIRIDIAN THERAPEUTICS INC | COM | $14.0M | 4.9%Prev: 4.4% | 450,000 SH | Increased-150,000 SH |
| X4 PHARMACEUTICALS INC | COM NEW | $10.4M | 3.7%Prev: 1.8% | 2,605,920 SH | Increased+1,061,313 SH |
| XERIS BIOPHARMA HOLDGS INC | COM | $16.6M | 5.8% | 2,111,700 SH | New |
| 13F-HR |
| 0001622627-26-000022 |
| $269.2M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001622627-25-000028 | $210.9M | View |
| May 14, 2026 | Q1 2026 | 13F-HR | 0001622627-26-000015 | $248.9M | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0001622627-25-000027 | $205.6M | View |